Clinical Trial

Prospective Study on Diabetes Mellitus and Its Complications in Newly Diagnosed Adult Patients

Study acronym: GDC
Recruiting
View on ClinicalTrials.gov →
Summary
The aim of the prospective observational GDC-Study in patients with newly diagnosed diabetes mellitus aged 18-69 years at inclusion into the study is to characterize in detail the clinical, metabolical and immunological phenotype and monitor the progression of the disease and to compare the phenotype to glucose tolerant humans of similar age, body mass and sex distribution.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2010-01-22; most recent amendment 2025-07-12.
Trial Details
NCT Number NCT01055093
Lead Sponsor German Diabetes Center
Conditions Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
Enrollment 2,000 participants
Start Date 2005-09
Primary Completion 2030-09 (estimated)
Study Completion 2040-09 (estimated)
Updated on ClinicalTrials.gov 2025-07-16